RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
RT @ScienceMagazine: A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%)…
A modeling analysis of immunity to #SARSCOV2 in France this month, as lockdown restrictions ease, estimates low (4.4%) immunity, suggesting efficient control measures that limit virus transmission need to be maintained to avoid a rebound of the epidemic ht
Un análisis de modelado de la inmunidad al #SARSCOV2 en Francia, estima una inmunidad baja (4.4%), lo que sugiere medidas de control eficientes que limitan la transmisión del virus deben mantenerse para evitar un rebote de la epidemia. https://t.co/Dr5BlaX